New research reveals that certain studies — clinical trials on drugs that appeared not to benefit patients with Alzheimer’s disease — should now be reanalyzed in light of recent discoveries about a gene called CHRFAM7A.
A literature review by a Jacobs School of Medicine and Biomedical Sciences researcher reveals two noteworthy findings related to COVID-19 and patients with neuromuscular disorders.
Jacobs School of Medicine and Biomedical Sciences researchers have published a paper that clarifies certain cellular mechanisms that could lead to improved outcomes in patients with globoid cell leukodystrophy, commonly known as Krabbe disease.
Two medical fellows, four medical residents and two medical students earned honors for outstanding poster presentations at the Office of Graduate Medical Education’s second annual Celebration of Scholarship.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a study detailing patterns of brain atrophy for patients with multiple sclerosis (MS) and other neurological diseases who are now living longer.
Three Jacobs School of Medicine and Biomedical Sciences faculty members wrote a chapter in the book “Neurological Disorders and Imaging Physics, Volume 3: Application to Autism Spectrum Disorders and Alzheimer’s.”
Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
Import medical school events to your personal calendar. Customize by selecting different event categories and receive automatic reminders of the school events that matter most to you.
